文献速递临床试验与 GCP

测试右美托咪定镇静治疗自我给药对危重机械通气患者焦虑、谵妄和通气天数疗效的研究方案:一项开放标签随机临床试验

Study protocol to test the efficacy of self-administration of dexmedetomidine sedative therapy on anxiety, delirium, and ventilator days in critically ill mechanically ventilated patients: an open-label randomized clinical trial.
PubMed 文献 · Trials · 2022-05-16

本研究为两中心开放标签随机临床试验,计划纳入190例能遵从指令自我管理镇静治疗的ICU机械通气患者,比较右美托咪定自我管理与常规护理对焦虑、谵妄及随机化后通气支持持续时间的影响。次要目标包括警觉水平、镇静及阿片类药物总暴露量和28天内无通气天数,探索性目标包括出院后3个月和6个月的身体功能状态、心理健康及ICU回忆。

要点

  • 两中心开放标签随机试验,纳入190例可遵从指令的ICU机械通气患者。
  • 主要比较右美托咪定自我管理与常规护理对焦虑、谵妄和通气持续时间的影响。
  • 患者自我管理镇静是缓解机械通气相关痛苦的新方法,可能不伴严重副作用。

核心结论

  • 本研究结果将为了解患者自我管理镇静法对机械通气患者短期和长期结局的疗效提供见解。

研究设计与样本

  • 两中心随机开放标签临床试验,计划纳入190例能遵从指令自我管理镇静治疗的ICU机械通气患者,随机分配至右美托咪定自我管理镇静组或常规护理组。
  • 患者只要仍接受机械通气,就留在ICU镇静药物研究阶段最多7天。

主要发现

  • 原文未报告结果。

关键数值与推荐

  • 主要目标:比较右美托咪定自我管理镇静与常规护理对焦虑、谵妄及随机化后通气支持持续时间的影响。
  • 次要目标:比较两组警觉水平、镇静及阿片类药物总暴露量、研究入组后至第28天的无通气天数。
  • 探索性目标:比较两组出院后3个月和6个月的身体和功能状态、心理健康(抑郁、创伤后应激障碍症状)、健康相关生活质量及对ICU护理的回忆。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 在5年临床试验期间,危重机械通气患者的护理可能发生显著变化。
  • 镇静和疼痛干预、氧合方法及拔管相关标准的变化已实质性影响符合条件患者数量随时间的一致性。
  • COVID-19大流行导致试验入组被强制延长暂停,并出于研究人员安全和防护设备可用性的考虑改变了招募方法。
  • 因COVID-19病例导致的医疗机构间患者分诊也造成符合条件研究人群的可及性不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Administration of sedative and opioid medications to patients receiving mechanical ventilatory support in the intensive care unit is a common clinical practice. METHODS: A two-site randomized open-label clinical trial will test the efficacy of self-management of sedative therapy with dexmedetomidine compared to usual care on anxiety, delirium, and duration of ventilatory support after randomization. Secondary objectives are to compare self-management of sedative therapy to usual care on level of alertness, total aggregate sedative and opioid medication exposure, and ventilator-free days up to day 28 after study enrolment. Exploratory objectives of the study are to compare self-management of sedative therapy to usual care on 3- and 6-month post-discharge physical and functional status, psychological well-being (depression, symptoms of post-traumatic stress disorder), health-related quality of life, and recollections of ICU care. ICU patients (n = 190) who are alert enough to follow commands to self-manage sedative therapy are randomly assigned to self-management of sedative therapy or usual care. Patients remain in the ICU sedative medication study phase for up to 7 days as long as mechanically ventilated. DISCUSSION: The care of critically ill mechanically ventilated patients can change significantly over the course of a 5-year clinical trial. Changes in sedation and pain interventions, oxygenation approaches, and standards related to extubation have substantially impacted consistency in the number of eligible patients over time. In addition, the COVID-19 pandemic resulted in mandated extended pauses in trial enrolment as well as alterations in recruitment methods out of concern for study personnel safety and availability of protective equipment. Patient triaging among healthcare institutions due to COVID-19 cases also has resulted in inconsistent access to the eligible study population. This has made it even more imperative for the study team to be flexible and innovative to identify and enrol all eligible participants. Patient-controlled sedation is a novel approach to the management of patient symptoms that may be able to alleviate mechanical ventilation-induced distress without serious side effects. Findings from this study will provide insight into the efficacy of this approach on short- and long-term outcomes in a subset of mechanically ventilated patients. TRIAL REGISTRATION: ClinicalTrials.gov NCT02819141. Registered on June 29, 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chlan LL, Weinert CR, Tracy MF, et al. Study protocol to test the efficacy of self-administration of dexmedetomidine sedative therapy on anxiety, delirium, and ventilator days in critically ill mechanically ventilated patients: an open-label randomized clinical trial. Trials. 2022. PMID: 35578315. doi:10.1186/s13063-022-06391-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。